Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice - Wikidata - awgldk - TriplyDB

Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice

Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice

http://www.wikidata.org/entity/Q24647376

about

Proteoglycan form and function: A comprehensive nomenclature of proteoglycans Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity Glycosaminoglycan remodeling during diabetes and the role of dietary factors in their modulation Proteoglycans in liver cancer The Interaction between Fluid Wall Shear Stress and Solid Circumferential Strain Affects Endothelial Gene Expression Transmembrane proteoglycans control stretch-activated channels to set cytosolic calcium levels.Syndecan-1 and Its Expanding List of Contacts Transmembrane Protein 184A Is a Receptor Required for Vascular Smooth Muscle Cell Responses to Heparin Guanidinylated neomycin mediates heparan sulfate-dependent transport of active enzymes to lysosomes.Transmembrane and extracellular domains of syndecan-1 have distinct functions in regulating lung epithelial migration and adhesion.Insulin-dependent diabetes mellitus in mice does not alter liver heparan sulfate SULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus.Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans Role of heparanase on hepatic uptake of intestinal derived lipoprotein and fatty streak formation in mice.Endogenous synthesis of n-3 polyunsaturated fatty acids in Fat-1 mice is associated with increased mammary gland and liver syndecan-1.Syndecan-1 is required to maintain intradermal fat and prevent cold stress.Low density lipoprotein receptor-related protein 1 dependent endosomal trapping and recycling of apolipoprotein E.Tumorigenic and adhesive properties of heparanase.A genome-wide association analysis for porcine serum lipid traits reveals the existence of age-specific genetic determinants.Impaired LDL receptor-related protein 1 translocation correlates with improved dyslipidemia and atherosclerosis in apoE-deficient mice.Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins Vitamin A metabolism: an update.Reducing macrophage proteoglycan sulfation increases atherosclerosis and obesity through enhanced type I interferon signaling.Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms.Genetic variation in SULF2 is associated with postprandial clearance of triglyceride-rich remnant particles and triglyceride levels in healthy subjects Heparan sulfate proteoglycans.Syndecan-1 regulates vascular smooth muscle cell phenotype.Triglycerides and heart disease: still a hypothesis?Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans.Syndecan 4 is involved in mediating HCV entry through interaction with lipoviral particle-associated apolipoprotein E Cell communication using intrinsically disordered proteins: what can syndecans say?The chylomicron: relationship to atherosclerosis.Novel method for reducing plasma cholesterol: a ligand replacement therapy.Shedding of syndecan-1 from human hepatocytes alters very low density lipoprotein clearance.LDL Receptor-Related Protein-1 (LRP1) Regulates Cholesterol Accumulation in Macrophages.Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion.Inhibition of hepatic sulfatase-2 in vivo: a novel strategy to correct diabetic dyslipidemia.Low Soluble Syndecan-1 Precedes Preeclampsia.Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism.The agouti-related peptide binds heparan sulfate through segments critical for its orexigenic effects.

P2860

Q21710680-D04F405D-4343-4310-943D-B3735C4493F5 Q24336040-3E0AB8E3-5346-44DF-80A1-CBDEA29D7BD2 Q26766645-884092D8-1E0C-426F-AAF3-591B7FEAB39E Q26772304-47E06E55-6CD3-4967-9526-D74765AA65B8 Q27304516-A835B8C3-0A2B-4576-85C4-D0AA70D041CC Q27310200-0FF79B69-6F98-4E9B-9A80-D7572D6A8D5F Q28084514-EA3D3658-B110-4A34-961D-D2081D7205CD Q28567433-883E6E1F-BAD0-4172-92A1-4A09BB2AAB9B Q30495726-AE8CA61C-CF97-4C9B-887C-0652C3110686 Q30525661-B879AB9D-AD41-4181-9C14-625E7D932FA1 Q33541795-6E6A85DB-C17A-42BA-9ABA-86FFEBC4D809 Q33560966-66C1EEE5-B57B-4AA5-9C51-5BF8A6B19C4A Q33750290-11616B37-9708-4CFD-BDC3-15862CB9A571 Q33869288-837774CF-51B2-42BE-8060-9602D3A99161 Q33927026-D2F01355-9B78-47EB-BA45-CA84115EC738 Q34015240-908EE690-5029-4FBD-BDFD-728390627C05 Q34125060-32BE9187-FF98-4CE3-AD33-59C126C12D9B Q34137792-65E93C07-FF3E-4729-95C3-17633093A581 Q34184693-E5682285-2F97-475A-9A1F-597EA8C081C9 Q34305393-91CCB7C4-7242-4F86-AE7B-10EAF810E6F4 Q34348377-E059C520-A6E7-4A2A-9504-FB881FC1E487 Q34591540-239E5EE0-B3DE-4C9E-ADFB-FF4985F82209 Q34625670-DF89A415-38FC-4EF8-A209-E0D352435249 Q34628212-8776D408-7760-426E-A326-253E68203ACA Q35053168-CFBE2A6C-996E-41B2-A41C-23D2DF9FA1DA Q35059448-E22D83E0-76C1-4943-B8F9-18738423964F Q35108169-69A9CE16-1B43-4A3B-837F-69D3AA93E2E1 Q35120360-A6D05BAA-17D1-4F64-BB01-E16C905C7888 Q35120945-D6DC6358-4D0B-43A9-BDC3-F0BCD3B1B655 Q35153978-4F19668E-A85D-4DA3-AC96-DC74EBD80A51 Q35193252-36CC6F99-D149-4767-B379-D3FB7F846458 Q35295065-893CB4FE-EC1B-4639-8496-FF18DA26D8CF Q35558371-03E1218A-9598-4F5F-9192-B2450D4F9F8F Q35631767-1E3C12BB-C554-42B5-BC72-55D552E15474 Q35659751-7D14D5D9-AC3F-49C3-8435-7FAB0B41D3B3 Q35776630-DEABF0BC-B450-4159-A9A4-A36922E3528B Q35936964-1EF82ECE-E063-4085-ABF3-9644690E61ED Q36051671-ECF62D6A-EE45-488E-9D7C-B44F734D7A36 Q36129135-87CD18F6-6AFF-4CC9-BC36-20B19761E473 Q36298889-1BB762EB-40D4-492D-B5E0-454E98FD8B46

P2860

Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice

http://www.wikidata.org/entity/Q24647376

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Syndecan-1 is the primary hepa ...... ride-rich lipoproteins in mice

@ast

Syndecan-1 is the primary hepa ...... ride-rich lipoproteins in mice

@en

Syndecan-1 is the primary hepa ...... ride-rich lipoproteins in mice

@nl

type

label

Syndecan-1 is the primary hepa ...... ride-rich lipoproteins in mice

@ast

Syndecan-1 is the primary hepa ...... ride-rich lipoproteins in mice

@en

Syndecan-1 is the primary hepa ...... ride-rich lipoproteins in mice

@nl

prefLabel

Syndecan-1 is the primary hepa ...... ride-rich lipoproteins in mice

@ast

Syndecan-1 is the primary hepa ...... ride-rich lipoproteins in mice

@en

Syndecan-1 is the primary hepa ...... ride-rich lipoproteins in mice

@nl

P1433

Q24647376-B9EB4956-1D70-4F97-88DE-71B165CA2261

P1476

Q24647376-9F960985-F69C-4CA8-B445-FB596BC49F41

P2093

Q24647376-071B4127-F3F3-4F23-86C8-CF0459F1F941

Q24647376-2F8CDB24-01C1-41CB-B46F-130ACCF7A35B

Q24647376-50B814AE-7052-4411-8165-4CC0D869E94E

Q24647376-54F473EF-A7E4-431E-9A01-459395AE3550

Q24647376-851B3280-CFFF-40EF-8D80-8565A6E25415

Q24647376-EA35FC81-FD3B-4197-93C9-5858FFEBBC95

P2860

Q24647376-0F62ABCE-2A33-4709-9810-5DF9C83471FD

Q24647376-193BFC61-00BB-464C-98A8-BD9DDBA20368

Q24647376-196B3D29-0FBD-4C84-A744-0E97D173EDAD

Q24647376-227A7D6C-0212-4F73-9FAB-3D3CD92211C2

Q24647376-29AC3394-F4AD-4561-B5F3-7C96BA8752A6

Q24647376-2D63E8E7-0F0D-49BB-8FE5-E7FD7BF18BB2

Q24647376-30612206-17C6-4B9D-920F-08955C0365D8

Q24647376-32022D4D-2E0C-4157-A24F-2EA1F75F5321

Q24647376-355FECE3-DFBA-4BF0-A96A-DF403BA815A4

Q24647376-3943C584-1DCB-45C6-9196-07ADA4C822A3

P304

Q24647376-29E66B66-1357-4C0E-A512-591E2C8E89CF

P31

Q24647376-14BFB320-C6C2-4493-8BEF-3CC38A1F502C

P3181

Q24647376-E346B0CE-572E-46DB-B5CF-898311AC61D5

P356

Q24647376-7DB9E737-2986-4D6F-B425-2A49BC23CD77

P407

Q24647376-43E00222-69DF-4ECF-BFF9-14E031E0C391

P433

Q24647376-C961C4A8-B8A0-4AA0-B42E-2064C3FF75F1

P478

Q24647376-12D43B70-2514-4BAB-A789-9D1D9D13A254

P50

Q24647376-33FE4F60-B71C-430B-9892-2EF96A13CC97

P577

Q24647376-55D4D0B7-665A-4640-B29B-719861AC9E65

P5875

Q24647376-974F2AC3-B65B-4DFA-B046-80216C4BB15A

P698

Q24647376-40B564AD-70C3-4CFD-97D9-D9051E247C1E

P921

Q24647376-0BC7C6B9-9D41-4783-B385-7606E915F427

Q24647376-31392DC2-859B-4B8B-9B59-3D07FFC10E98

P932

Q24647376-BF92F4A9-0E19-44FB-A5C0-1CE38BE82580

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Syndecan-1 is the primary hepa ...... ride-rich lipoproteins in mice

@en

P2093

Erin M Foley

http://www.w3.org/2001/XMLSchema#string

Ingrid R Niesman

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Esko

http://www.w3.org/2001/XMLSchema#string

Jon C Gonzales

http://www.w3.org/2001/XMLSchema#string

Joseph R Bishop

http://www.w3.org/2001/XMLSchema#string

Kristin I Stanford

http://www.w3.org/2001/XMLSchema#string

P2860

Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling

Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants

Molecular processes that handle -- and mishandle -- dietary lipids

Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons

Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4

Plaque formation and isolation of pure lines with poliomyelitis viruses

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Interaction of the N-terminal domain of apolipoprotein E4 with heparin

Syndecan-1 expression is regulated in an isoform-specific manner by the farnesoid-X receptor

Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans

P304

3236-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

826598

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI38251

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Joseph L Witztum

P577

2009-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26872054

http://www.w3.org/2001/XMLSchema#string

P698

19805913

http://www.w3.org/2001/XMLSchema#string

P921

P932

2769193

http://www.w3.org/2001/XMLSchema#string